Are overweight or have obesity, especially if they also have diabetes or other health risks (Trulicity and Mounjaro are not indicated for the treatment of overweight or obesity, however)
doi: 10.1111/dom.12849 153 WhartonSCalannaSDaviesMDickerDGoldmanBLingvayIet al
The FDA's staff reviewers had last month said there is little evidence to support the safety and effectiveness of these peptides for their intended uses and flagged a lack of adequate human clinical trials, in contrast to Kennedy's public support
Microbiome mediation is untested : gut microbiome changes with GLP-1 therapy are documented, but direct consequences for the vaginal microbiome and infection risk in semaglutide users are not established
At Josie, we hear it all the time from women in their late 30s, 40s, and 50s: Im doing everything right eating less, moving more so why isnt it working anymore? In this article, well break down how GLP-1s work with your biology, what to expect, and why this approach is helping so many women feel like themselves again
Then weekly photos through week 12, bi-weekly weeks 13-24, and monthly weeks 25-48
